FBLN2 and breast carcinoma: To investigate the preferential expression of FBLN2 in basal cells in human breast cancer, we retrieved online datasets from the Bioportal [28–30] (METABRIC dataset) and assessed the correlation between mRNA levels of Fbln2 and the available data on luminal, myoepithelial, EMT, stemness, and mesenchymal markers.